241 related articles for article (PubMed ID: 21858086)
21. Plumbagin inhibits tumour angiogenesis and tumour growth through the Ras signalling pathway following activation of the VEGF receptor-2.
Lai L; Liu J; Zhai D; Lin Q; He L; Dong Y; Zhang J; Lu B; Chen Y; Yi Z; Liu M
Br J Pharmacol; 2012 Feb; 165(4b):1084-96. PubMed ID: 21658027
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of mutant KRAS-driven overexpression of ARF6 and MYC by an eIF4A inhibitor drug improves the effects of anti-PD-1 immunotherapy for pancreatic cancer.
Hashimoto A; Handa H; Hata S; Tsutaho A; Yoshida T; Hirano S; Hashimoto S; Sabe H
Cell Commun Signal; 2021 May; 19(1):54. PubMed ID: 34001163
[TBL] [Abstract][Full Text] [Related]
23. Brag2 differentially regulates β1- and β3-integrin-dependent adhesion in endothelial cells and is involved in developmental and pathological angiogenesis.
Manavski Y; Carmona G; Bennewitz K; Tang Z; Zhang F; Sakurai A; Zeiher AM; Gutkind JS; Li X; Kroll J; Dimmeler S; Chavakis E
Basic Res Cardiol; 2014 Mar; 109(2):404. PubMed ID: 24522833
[TBL] [Abstract][Full Text] [Related]
24. Rab5c promotes AMAP1-PRKD2 complex formation to enhance β1 integrin recycling in EGF-induced cancer invasion.
Onodera Y; Nam JM; Hashimoto A; Norman JC; Shirato H; Hashimoto S; Sabe H
J Cell Biol; 2012 Jun; 197(7):983-96. PubMed ID: 22734003
[TBL] [Abstract][Full Text] [Related]
25. Arf6 regulates tumour angiogenesis and growth through HGF-induced endothelial β1 integrin recycling.
Hongu T; Funakoshi Y; Fukuhara S; Suzuki T; Sakimoto S; Takakura N; Ema M; Takahashi S; Itoh S; Kato M; Hasegawa H; Mochizuki N; Kanaho Y
Nat Commun; 2015 Aug; 6():7925. PubMed ID: 26239146
[TBL] [Abstract][Full Text] [Related]
26. CIN85, a Cbl-interacting protein, is a component of AMAP1-mediated breast cancer invasion machinery.
Nam JM; Onodera Y; Mazaki Y; Miyoshi H; Hashimoto S; Sabe H
EMBO J; 2007 Feb; 26(3):647-56. PubMed ID: 17255943
[TBL] [Abstract][Full Text] [Related]
27. Integrin alpha x stimulates cancer angiogenesis through PI3K/Akt signaling-mediated VEGFR2/VEGF-A overexpression in blood vessel endothelial cells.
Wang J; Yang L; Liang F; Chen Y; Yang G
J Cell Biochem; 2019 Feb; 120(2):1807-1818. PubMed ID: 30873824
[TBL] [Abstract][Full Text] [Related]
28. Sulfated fucoidan FP08S2 inhibits lung cancer cell growth in vivo by disrupting angiogenesis via targeting VEGFR2/VEGF and blocking VEGFR2/Erk/VEGF signaling.
Chen H; Cong Q; Du Z; Liao W; Zhang L; Yao Y; Ding K
Cancer Lett; 2016 Nov; 382(1):44-52. PubMed ID: 27569654
[TBL] [Abstract][Full Text] [Related]
29. Epidermal growth factor receptor-GEP100-Arf6 axis affects the prognosis of lung adenocarcinoma.
Oka S; Uramoto H; Shimokawa H; Yamada S; Tanaka F
Oncology; 2014; 86(5-6):263-70. PubMed ID: 24902879
[TBL] [Abstract][Full Text] [Related]
30. BET Bromodomain Suppression Inhibits VEGF-induced Angiogenesis and Vascular Permeability by Blocking VEGFR2-mediated Activation of PAK1 and eNOS.
Huang M; Qiu Q; Xiao Y; Zeng S; Zhan M; Shi M; Zou Y; Ye Y; Liang L; Yang X; Xu H
Sci Rep; 2016 Apr; 6():23770. PubMed ID: 27044328
[TBL] [Abstract][Full Text] [Related]
31. Expression of AMAP1, an ArfGAP, provides novel targets to inhibit breast cancer invasive activities.
Onodera Y; Hashimoto S; Hashimoto A; Morishige M; Mazaki Y; Yamada A; Ogawa E; Adachi M; Sakurai T; Manabe T; Wada H; Matsuura N; Sabe H
EMBO J; 2005 Mar; 24(5):963-73. PubMed ID: 15719014
[TBL] [Abstract][Full Text] [Related]
32. The guanine nucleotide exchange protein for ADP-ribosylation factor 6, ARF-GEP100/BRAG2, regulates phagocytosis of monocytic phagocytes in an ARF6-dependent process.
Someya A; Moss J; Nagaoka I
J Biol Chem; 2010 Oct; 285(40):30698-707. PubMed ID: 20601426
[TBL] [Abstract][Full Text] [Related]
33. Norcantharidin inhibits tumor angiogenesis via blocking VEGFR2/MEK/ERK signaling pathways.
Zhang L; Ji Q; Liu X; Chen X; Chen Z; Qiu Y; Sun J; Cai J; Zhu H; Li Q
Cancer Sci; 2013 May; 104(5):604-10. PubMed ID: 23363445
[TBL] [Abstract][Full Text] [Related]
34. Machineries regulating the activity of the small GTPase Arf6 in cancer cells are potential targets for developing innovative anti-cancer drugs.
Yamauchi Y; Miura Y; Kanaho Y
Adv Biol Regul; 2017 Jan; 63():115-121. PubMed ID: 27776975
[TBL] [Abstract][Full Text] [Related]
35. Eriocalyxin B, a natural diterpenoid, inhibited VEGF-induced angiogenesis and diminished angiogenesis-dependent breast tumor growth by suppressing VEGFR-2 signaling.
Zhou X; Yue GG; Liu M; Zuo Z; Lee JK; Li M; Tsui SK; Fung KP; Sun H; Pu J; Lau CB
Oncotarget; 2016 Dec; 7(50):82820-82835. PubMed ID: 27756875
[TBL] [Abstract][Full Text] [Related]
36. Evogliptin, a dipeptidyl peptidase-4 inhibitor, attenuates pathological retinal angiogenesis by suppressing vascular endothelial growth factor-induced Arf6 activation.
Seo S; Kim MK; Kim RI; Yeo Y; Kim KL; Suh W
Exp Mol Med; 2020 Oct; 52(10):1744-1753. PubMed ID: 33051573
[TBL] [Abstract][Full Text] [Related]
37. VEGFR3 Modulates Vascular Permeability by Controlling VEGF/VEGFR2 Signaling.
Heinolainen K; Karaman S; D'Amico G; Tammela T; Sormunen R; Eklund L; Alitalo K; Zarkada G
Circ Res; 2017 Apr; 120(9):1414-1425. PubMed ID: 28298294
[TBL] [Abstract][Full Text] [Related]
38. A novel synthetic small molecule YF-452 inhibits tumor growth through antiangiogenesis by suppressing VEGF receptor 2 signaling.
Liu Y; He Y; Yang F; Cong X; Wang J; Peng S; Gao D; Wang W; Lan L; Ying X; Liu M; Chen Y; Yi Z
Sci China Life Sci; 2017 Feb; 60(2):202-214. PubMed ID: 28194552
[TBL] [Abstract][Full Text] [Related]
39. Single chain precursor prohaptoglobin promotes angiogenesis by upregulating expression of vascular endothelial growth factor (VEGF) and VEGF receptor2.
Oh MK; Park HJ; Lee JH; Bae HM; Kim IS
FEBS Lett; 2015 Apr; 589(9):1009-17. PubMed ID: 25775978
[TBL] [Abstract][Full Text] [Related]
40. Co-overexpression of GEP100 and AMAP1 proteins correlates with rapid local recurrence after breast conservative therapy.
Kinoshita R; Nam JM; Ito YM; Hatanaka KC; Hashimoto A; Handa H; Otsuka Y; Hashimoto S; Onodera Y; Hosoda M; Onodera S; Shimizu S; Tanaka S; Shirato H; Tanino M; Sabe H
PLoS One; 2013; 8(10):e76791. PubMed ID: 24116160
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
